AU7595300A - Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs - Google Patents

Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs

Info

Publication number
AU7595300A
AU7595300A AU75953/00A AU7595300A AU7595300A AU 7595300 A AU7595300 A AU 7595300A AU 75953/00 A AU75953/00 A AU 75953/00A AU 7595300 A AU7595300 A AU 7595300A AU 7595300 A AU7595300 A AU 7595300A
Authority
AU
Australia
Prior art keywords
dogs
cognitive dysfunction
chewable tablet
dysfunction syndrome
treating cognitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75953/00A
Inventor
Elizabeth M. Abbott
Susan M. Cady
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU7595300A publication Critical patent/AU7595300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AU75953/00A 1999-09-22 2000-09-21 Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs Abandoned AU7595300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40153299A 1999-09-22 1999-09-22
US09401532 1999-09-22
PCT/US2000/025771 WO2001021178A2 (en) 1999-09-22 2000-09-21 Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs

Publications (1)

Publication Number Publication Date
AU7595300A true AU7595300A (en) 2001-04-24

Family

ID=23588149

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75953/00A Abandoned AU7595300A (en) 1999-09-22 2000-09-21 Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs

Country Status (2)

Country Link
AU (1) AU7595300A (en)
WO (1) WO2001021178A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2884421B1 (en) 2005-04-15 2007-08-10 Virbac Sa NEW MEANS FOR CONTROLLING BEHAVIORAL DISORDERS IN PETS
JP2010504337A (en) * 2006-09-20 2010-02-12 メディベイション ニューロロジー， インコーポレイテッド Hydrogenated pyrido [4,3-b] indoles such as dimebon for the treatment of cognitive impairment syndrome in dogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937076A (en) * 1984-08-10 1990-06-26 Combe Incorporated Chewable aspirin and buffering material tablet and method for producing same
PT760648E (en) * 1994-05-20 2002-04-29 Janssen Pharmaceutica Nv TABLETS OF FLUBENDAZOLE OF MASTIGATION FOR DOMESTIC ANIMALS
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
ZA964928B (en) * 1995-06-13 1997-12-10 American Home Prod Oral formulations of S(+)-etodolac.

Also Published As

Publication number Publication date
WO2001021178A3 (en) 2002-07-11
WO2001021178A2 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
AU2003277270B2 (en) Inorganic shaped bodies and methods for their production and use
AU3239800A (en) Method and apparatus for improving access to literature
AU3372000A (en) Stomach treatment apparatus and method
AU2373200A (en) Apparatuses and methods for forming assemblies
AU6375399A (en) Electromagnetic-field therapy method and device
AU1448601A (en) Gerd treatment apparatus and method
AU1160801A (en) Apparatus and method
AU2735200A (en) Device and method for stimulating salivation
AU2002329022A1 (en) Method and pharmaceutical composition for treating inflammation
AU7484500A (en) Cargo-transfer apparatus and method
AU3877900A (en) Compositions and methods for preventing and treating sexual dysfunctions
AUPP855599A0 (en) Apparatus and method
AU5838700A (en) Method for treating and preventing finger disorders
AU2562100A (en) Waste treatment apparatus and methods
AU1530801A (en) Waste treatment apparatus and methods
AU7595300A (en) Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
AU2744900A (en) Method and apparatus for manufacturing design
AU1024301A (en) Method and device for treating surfaces of objects
AU5406500A (en) Method and device for producing pellets
AU7577700A (en) Purification device and purification method
AU6099800A (en) Structure forming apparatus and method
AU5438801A (en) Method and device for cleaning areas of the pharynx
AU2461999A (en) Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions
AU1858301A (en) Method and device for annealing flat bodies
AU3537601A (en) Method and device for aligning bodies

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase